NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 126 filers reported holding NURIX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $989,095 | -9.0% | 125,839 | +15.6% | 0.00% | 0.0% |
| Q2 2023 | $1,087,412 | +18.0% | 108,850 | +4.9% | 0.00% | 0.0% |
| Q1 2023 | $921,558 | -21.2% | 103,779 | -2.5% | 0.00% | -33.3% |
| Q4 2022 | $1,169,139 | +32.6% | 106,479 | +57.4% | 0.01% | +20.0% |
| Q3 2022 | $882,000 | +425.0% | 67,655 | +410.0% | 0.01% | +400.0% |
| Q2 2022 | $168,000 | -7.7% | 13,265 | +2.0% | 0.00% | 0.0% |
| Q1 2022 | $182,000 | -51.6% | 13,005 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $376,000 | – | 13,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |